Title:
Operating Grant: SU2C Canada - Metastatic Breast Cancer Dream Team
Agreement Value:
$1,500,000.00
Agreement Date:
Apr 1, 2019 - Mar 31, 2023
Description:
The SU2C Canada – Metastatic Breast Cancer Dream Team funding opportunity is expected to focus the efforts of the Canadian research community on accelerating the pace of ground-breaking translational research on critical problems in metastatic breast cancer.
The successful Dream Team:
Will develop a translational cancer research project that addresses critical problems in metastatic cancer patient care, including prevention strategies for those at risk and gaining a mechanistic understanding of metastatic progression.
Will design and carry out projects that accelerate the application of preventative, diagnostic or therapeutic approaches to the clinic.
Will include plans describing how the work will be translated into the clinic. The ideas should be based on perceived opportunities for success as well as high-priority areas with a critical need for rapid progress beyond current medical care.
Organization:
Canadian Institutes of Health Research
Expected Results:
This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.
Location:
Montreal, Quebec, CA H3A 2T5
Reference Number:
236-2019-2020-Q1-00365
Report Type:
Grants and Contributions
Recipient Type:
Individual or sole proprietorship
Recipient's Legal Name:
Sonenberg, Nahum
Research Organization:
McGill University|Université McGill
Program:
Research in Priority Areas
Program Purpose:
This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.